Valvular & structural heart disease
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry
Authors' conclusion
A-STR is a common phenotype of STR and is associated with effective TR reduction and symptomatic reduction after T-TEER.
Study context
- Population
- Patients undergoing T-TEER for secondary tricuspid regurgitation, EuroTR registry, 2016–202250% women
- Participants
- 641 patients
- Exposure
- Atrial secondary tricuspid regurgitation (A-STR) vs nonatrial STR after T-TEER
- Outcome
- Survival free from HF hospitalization
- Follow-up
- 2 years
Methodological detailsmulticentre registry (EuroTR)
- Multicentre registry (EuroTR)
Main finding
As reported in the abstract
P < 0.001
Observational data: associations, not effects.
Secondary outcomes
Procedural TR reduction (TR ≤2+)
P = 0.005
NYHA class ≥III · latest available follow-up
P = 0.033
Prevalence of A-STR
- Overall prevalence of A-STR
- 31%
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry. JACC Cardiovasc Interv. Published 9 December 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →